Abstract
β-Coronaviruses are a family of positive-strand enveloped RNA viruses that includes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Much is known regarding their cellular entry and replication pathways, but their mode of egress remains uncertain. Using imaging methodologies and virus-specific reporters, we demonstrate that β-coronaviruses utilize lysosomal trafficking for egress rather than the biosynthetic secretory pathway more commonly used by other enveloped viruses. This unconventional egress is regulated by the Arf-like small GTPase Arl8b and can be blocked by the Rab7 GTPase competitive inhibitor CID1067700. Such non-lytic release of β-coronaviruses results in lysosome deacidification, inactivation of lysosomal degradation enzymes, and disruption of antigen presentation pathways. β-Coronavirus-induced exploitation of lysosomal organelles for egress provides insights into the cellular and immunological abnormalities observed in patients and suggests new therapeutic modalities.
Original language | English |
---|---|
Pages (from-to) | 1520-1535.e14 |
Journal | Cell |
Volume | 183 |
Issue number | 6 |
Early online date | 2020 |
DOIs | |
Publication status | Published - 10 Dec 2020 |
Keywords
- coronavirus
- SARS-CoV-2
- viral egress
- lysosome
- pH
- viral immunology
- antigen presentation
- acidification/deacidification ARL8b
- Rab7
- CD1067700